Filing Details
- Accession Number:
- 0001127602-10-009327
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-23 13:00:00
- Reporting Period:
- 2010-03-19
- Filing Date:
- 2010-03-23
- Accepted Time:
- 2010-03-23 16:36:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226288 | C James Mullen | 14 Cambridge Center Cambridge MA 02142 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-19 | 287,500 | $51.85 | 418,649 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-03-19 | 46,721 | $49.03 | 465,370 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-19 | 334,221 | $59.97 | 131,149 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-03-22 | 106,279 | $49.03 | 237,428 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-22 | 106,279 | $59.95 | 131,149 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2010-03-19 | 287,500 | $0.00 | 287,500 | $51.85 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2010-03-19 | 46,721 | $0.00 | 46,721 | $49.03 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2010-03-22 | 106,279 | $0.00 | 106,279 | $49.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-06-16 | No | 4 | M | Direct | |
| 355,779 | 2011-12-14 | No | 4 | M | Direct | |
| 249,500 | 2011-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 75,000 | Indirect | 2008 GRAT |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price for shares sold at a range between $59.95 (low) and $60.15 (high).
- This represents the weighted average price for shares sold at a range between $59.95 (low) and $59.98 (high).
- The stock option became exercisable in seven (7) equal annual installments, commencing one year after the grant date of 06/16/00.
- The stock option became exercisable in four (4) equal annual installments, commencing one year after the grant date of 12/14/01.
- Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
Billionaire Hedge Funds
